State of Alaska Department of Revenue Boosts Stake in Balchem Co. (NASDAQ:BCPC)

State of Alaska Department of Revenue grew its position in shares of Balchem Co. (NASDAQ:BCPCGet Rating) by 7.5% during the second quarter, according to its most recent filing with the SEC. The firm owned 24,290 shares of the basic materials company’s stock after acquiring an additional 1,705 shares during the period. State of Alaska Department of Revenue owned about 0.08% of Balchem worth $3,151,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Maryland State Retirement & Pension System boosted its position in shares of Balchem by 0.6% in the 1st quarter. Maryland State Retirement & Pension System now owns 12,985 shares of the basic materials company’s stock worth $1,775,000 after purchasing an additional 75 shares in the last quarter. Advisor Partners LLC boosted its position in shares of Balchem by 5.2% in the 1st quarter. Advisor Partners LLC now owns 1,680 shares of the basic materials company’s stock worth $230,000 after purchasing an additional 83 shares in the last quarter. American Research & Management Co. boosted its position in shares of Balchem by 1.5% in the 1st quarter. American Research & Management Co. now owns 7,894 shares of the basic materials company’s stock worth $1,079,000 after purchasing an additional 119 shares in the last quarter. Hudson Valley Investment Advisors Inc. ADV boosted its position in shares of Balchem by 3.7% in the 1st quarter. Hudson Valley Investment Advisors Inc. ADV now owns 3,658 shares of the basic materials company’s stock worth $500,000 after purchasing an additional 130 shares in the last quarter. Finally, Great West Life Assurance Co. Can boosted its position in shares of Balchem by 0.5% in the 1st quarter. Great West Life Assurance Co. Can now owns 28,110 shares of the basic materials company’s stock worth $3,943,000 after purchasing an additional 132 shares in the last quarter. Hedge funds and other institutional investors own 89.15% of the company’s stock.

Analyst Upgrades and Downgrades

BCPC has been the topic of a number of analyst reports. HC Wainwright boosted their price target on Balchem from $152.00 to $164.00 and gave the stock a “buy” rating in a research report on Monday, August 22nd. StockNews.com cut Balchem from a “buy” rating to a “hold” rating in a research report on Monday, August 1st.

Balchem Stock Performance

BCPC stock opened at $122.00 on Friday. The stock has a market capitalization of $3.92 billion, a PE ratio of 36.53 and a beta of 0.59. Balchem Co. has a 12-month low of $110.15 and a 12-month high of $174.29. The company has a current ratio of 2.62, a quick ratio of 1.64 and a debt-to-equity ratio of 0.50. The stock’s 50 day simple moving average is $131.46 and its 200 day simple moving average is $129.19.

Insider Activity at Balchem

In other Balchem news, VP Gunsteren Job Leonard Van sold 1,000 shares of the business’s stock in a transaction on Friday, August 12th. The shares were sold at an average price of $131.12, for a total transaction of $131,120.00. Following the completion of the sale, the vice president now directly owns 1,430 shares in the company, valued at approximately $187,501.60. The sale was disclosed in a document filed with the SEC, which is available through this link. 1.60% of the stock is currently owned by insiders.

Balchem Profile

(Get Rating)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Featured Articles

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.